News und Analysen

As the AI trend continues to push the major indices higher, concerns about overextension amid record-high valuations should have some investors considering whether to lock in gains on high-flying

Resideo Technologies' (NYSE: REZI) is gaining serious traction with institutional investors, setting new records in Q3 2025 and driving a robust technical outlook.

The stock's recent breakout

With the major indices continuing to set fresh records, it can be tough for investors to feel comfortable buying into names already trading at highs. However, at the other end of the spectrum, it

While no business is recession-proof, specific sectors offer investors recession-resistant stocks whose products and services are inelastic in demand—even during market or economic downturns. With

On Sept. 9, one of the world’s biggest tech stocks, Oracle (NYSE: ORCL), provided key information that blew investors away. Shares closed up by 36% on Sept. 10 in reaction to the company's

Two key names just increased their dividends, and another winner in artificial intelligence is likely to do the same by year's end.

Below, we’ll examine these three stocks and outline the yield

Shares of Applied Digital Corp. (NASDAQ: APLD) recently hit a new 52-week high, which might scare some investors away, worried about buying at the top of the cycle or valuation limits. However,

The small-cap tech markets are heating up. The outlook for interest rate reduction and business demand trends has many underlying companies set up for hyper growth and stocks for significant price

The biotech sector has been one of the market's laggards for several years now, and 2025 has been no different, at least on the surface. Year-to-date, the iShares Nasdaq Biotechnology ETF (NASDAQ:

Adobe’s (NASDAQ: ADBE) stock price is set up for a significant rebound that could add 25% to its share price by year’s end. This forecast is relative to a critical support target that aligns

While stocks like Oracle (NYSE: ORCL) had an incredible day on Sept. 10, one name stuck out like a sore thumb. That stock was Synopsys (NASDAQ: SNPS), a company that is among the most important

After a punishing year that saw its stock fall significantly from a 52-week high of over $630, UnitedHealth Group (NYSE: UNH) has reversed course with remarkable force.

The healthcare sector